AU7829687A - Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane A2 antagonist - Google Patents

Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane A2 antagonist

Info

Publication number
AU7829687A
AU7829687A AU78296/87A AU7829687A AU7829687A AU 7829687 A AU7829687 A AU 7829687A AU 78296/87 A AU78296/87 A AU 78296/87A AU 7829687 A AU7829687 A AU 7829687A AU 7829687 A AU7829687 A AU 7829687A
Authority
AU
Australia
Prior art keywords
thromboxane
antagonist
pharmaceutical composition
phosphodiesterase inhibitor
phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU78296/87A
Other versions
AU597718B2 (en
Inventor
Walter Haarmann
Josef Nickl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of AU7829687A publication Critical patent/AU7829687A/en
Application granted granted Critical
Publication of AU597718B2 publication Critical patent/AU597718B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
AU78296/87A 1986-09-13 1987-09-11 Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist Ceased AU597718B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3631294 1986-09-13
DE19863631294 DE3631294A1 (en) 1986-09-13 1986-09-13 NEW SYNERGISTIC COMBINATION CONSISTING OF A PHOSPHODIESTERASE INHIBITOR AND A THROMBOXAN-A (ARROW DOWN) 2 (ARROW DOWN) ANTAGONISTS AND THEIR USE OR THEIR USE. MANUFACTURING

Publications (2)

Publication Number Publication Date
AU7829687A true AU7829687A (en) 1988-03-17
AU597718B2 AU597718B2 (en) 1990-06-07

Family

ID=6309586

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78296/87A Ceased AU597718B2 (en) 1986-09-13 1987-09-11 Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist

Country Status (12)

Country Link
EP (1) EP0260527B1 (en)
JP (1) JPS6379838A (en)
KR (1) KR880003624A (en)
AU (1) AU597718B2 (en)
DE (2) DE3631294A1 (en)
DK (1) DK472487A (en)
ES (1) ES2033755T3 (en)
GR (1) GR3004969T3 (en)
IL (1) IL83872A0 (en)
NZ (1) NZ221779A (en)
PH (1) PH23553A (en)
ZA (1) ZA876806B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306846A3 (en) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Synergistic combination comprising a phosphodiesterase inhibitor and a thromboxane-a2 antagonist, and its use or preparation
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
EP1216037A2 (en) 1999-09-21 2002-06-26 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291368A (en) * 1979-03-30 1981-09-22 Borg-Warner Corporation Pulse-width modulated inverter system and method
DE3166627D1 (en) * 1980-12-12 1984-11-15 Thomae Gmbh Dr K Pyrimidones, their preparation and medicines containing them
DE3049207A1 (en) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach NEW TRISUBSTITUTED PYRIMIDO (5,4-D) PYRIMIDINE, THEIR PRODUCTION AND USE AS A MEDICINAL PRODUCT
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor

Also Published As

Publication number Publication date
EP0260527A3 (en) 1989-08-09
ES2033755T3 (en) 1993-04-01
DE3777926D1 (en) 1992-05-07
KR880003624A (en) 1988-05-28
GR3004969T3 (en) 1993-04-28
ZA876806B (en) 1989-05-30
IL83872A0 (en) 1988-02-29
EP0260527B1 (en) 1992-04-01
PH23553A (en) 1989-08-25
DE3631294A1 (en) 1988-03-24
AU597718B2 (en) 1990-06-07
EP0260527A2 (en) 1988-03-23
NZ221779A (en) 1990-03-27
JPS6379838A (en) 1988-04-09
DK472487A (en) 1988-03-14
DK472487D0 (en) 1987-09-10

Similar Documents

Publication Publication Date Title
AU3639989A (en) Scaffolding
AU3463389A (en) Diol-containing renin inhibitors
AU5434190A (en) Tablet dispenser
AU1235088A (en) Pharmaceutical plaster
AU4148989A (en) Pharmaceutical compositions
AU3674489A (en) Pharmaceutical compositions
AU4773390A (en) Theophylline dosage form
AU5573390A (en) Fluorogenic compounds and their use
AU4931693A (en) Ibuprofen-h2 antagonist combinations
AU3192289A (en) Nucleosidetype compounds which are phosphodiesterase inhibitors
IL96594A0 (en) Pharmaceutical compositions containing an antiallergic compound and an antihistamine
IL87721A0 (en) Synergistic pharmaceutical combinations comprising a pde inhibitor and a thromboxane a2 antagonist
AU1227292A (en) Pharmaceutical antitussive compositions
AU1189392A (en) Pharmaceutical agent
AU4721489A (en) Renin inhibitors
AU7829687A (en) Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane A2 antagonist
AU570612B2 (en) Alpha-glucosidase inhibitor, its preparation and pharmaceutical use
AU3893389A (en) Oxaza heterocycles and pharmaceutical compositions containing same
AU6012990A (en) Pharmaceutical formulation
AU616875B2 (en) Renin inhibitors iv
AU5061990A (en) Azacyclooctadiene compound and pharmaceutical use
AU4717389A (en) Renin inhibitors
AU6450590A (en) Renin inhibitors
AU3298589A (en) New pharmaceutical composition
AU2965989A (en) Renin inhibitors